BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lipitor
,
rs2300478
,
IGF1
,
Apoptosis
,
Obesity
,
Prostate
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PU.1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Whole blood
Neutrophil of bone marrow
Leukocyte (polymorphonuclear) of peripheral blood
Microglial cell
Mononuclear cell of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Fungal keratitis
Sepsis due to coagulase negative Staphylococcus
Fusarium infection
Systemic infection
Salmonella infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
poly ICLC
Ions
Chlorphenesin
piperaquine
dihydroquinghaosu
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PINK1
LYRM1
SPI1
CASP1
EN1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
DNA selection by the master transcription factor PU.1.
PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer.
Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents.
Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation.
Intracellular Salmonella Paratyphi A is motile and differs in the expression of flagella-chemotaxis,…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
PET Imaging of Subjects Using 124I-PU-AD
A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in H…
Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis
To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Demen…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ